Total Payments
$4,454
2024 Payments
$1,670
Companies
24
Transactions
120
Medicare Patients
3,999
Medicare Billing
$565,014
Payment Breakdown by Category
Food & Beverage$3,154 (70.8%)
Consulting$1,300 (29.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,154 | 119 | 70.8% |
| Consulting Fee | $1,300 | 1 | 29.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,738 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $593.63 | 26 | $0 (2024) |
| GlaxoSmithKline, LLC. | $523.87 | 27 | $0 (2024) |
| Pulmonx Corporation | $266.94 | 2 | $0 (2024) |
| INTUITIVE SURGICAL, INC. | $264.27 | 2 | $0 (2024) |
| Mylan Specialty L.P. | $158.94 | 9 | $0 (2024) |
| La Jolla Pharmaceutical Company | $133.17 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $79.57 | 4 | $0 (2024) |
| United Therapeutics Corporation | $74.21 | 5 | $0 (2023) |
| Amgen Inc. | $68.48 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,670 | 55 | AstraZeneca Pharmaceuticals LP ($370.65) |
| 2023 | $976.15 | 46 | AstraZeneca Pharmaceuticals LP ($208.20) |
| 2022 | $221.98 | 12 | W. L. Gore & Associates, Inc. ($50.70) |
| 2021 | $1,300 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,300) |
| 2018 | $175.09 | 1 | Intuitive Surgical, Inc. ($175.09) |
| 2017 | $110.07 | 5 | Shire North American Group Inc ($64.21) |
All Payment Transactions
120 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/05/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Immunology | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological), INBRIJA | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Musculoskeletal | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/22/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $89.18 | General |
| Category: SURGERY | ||||||
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $78.79 | General |
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $117.66 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $40.47 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Respiratory | ||||||
| 08/02/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Respiratory | ||||||
| 07/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: RESPIRATORY | ||||||
| 07/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: IMMUNOLOGY | ||||||
| 07/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/20/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $133.17 | General |
| Category: EMERGENT HYPOTENSION | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 980 | 1,335 | $501,128 | $118,943 |
| 2022 | 14 | 960 | 1,244 | $591,459 | $117,480 |
| 2021 | 15 | 1,085 | 1,481 | $754,502 | $165,874 |
| 2020 | 17 | 974 | 1,491 | $771,113 | $162,716 |
Total Patients
3,999
Total Services
5,551
Medicare Billing
$565,014
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 184 | 298 | $129,200 | $31,701 | 24.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 43 | 122 | $114,130 | $22,620 | 19.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 99 | 189 | $65,845 | $19,399 | 29.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 95 | 95 | $53,555 | $13,323 | 24.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 72 | 133 | $32,055 | $9,068 | 28.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 55 | $34,150 | $8,243 | 24.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 32 | 32 | $23,770 | $5,499 | 23.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 19 | $11,590 | $2,553 | 22.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 15 | $6,570 | $1,707 | 26.0% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2023 | 11 | 12 | $16,593 | $1,370 | 8.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 111 | 114 | $4,560 | $1,166 | 25.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 99 | 100 | $3,500 | $876.15 | 25.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 111 | 113 | $3,390 | $857.92 | 25.3% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 24 | 24 | $1,800 | $459.84 | 25.5% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 14 | 14 | $420.00 | $99.26 | 23.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 284 | 405 | $209,819 | $40,785 | 19.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 41 | 145 | $141,040 | $27,843 | 19.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 63 | 63 | $51,185 | $11,378 | 22.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 64 | 74 | $52,550 | $11,192 | 21.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 70 | 70 | $43,920 | $9,384 | 21.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 33 | $24,600 | $5,808 | 23.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 28 | 51 | $18,955 | $4,449 | 23.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $6,195 | $1,455 | 23.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 22 | $5,280 | $1,344 | 25.5% |
| 94375 | Test to measure rate of airflow | Facility | 2022 | 100 | 102 | $11,220 | $1,276 | 11.4% |
About Dr. Keith Brenner, M.D
Dr. Keith Brenner, M.D is a Pulmonary Disease healthcare provider based in Hackensack, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1316139686.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keith Brenner, M.D has received a total of $4,454 in payments from pharmaceutical and medical device companies, with $1,670 received in 2024. These payments were reported across 120 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,154).
As a Medicare-enrolled provider, Brenner has provided services to 3,999 Medicare beneficiaries, totaling 5,551 services with total Medicare billing of $565,014. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location Hackensack, NJ
- Active Since 08/10/2007
- Last Updated 09/02/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1316139686
Products in Payments
- OFEV (Drug) $1,434
- FASENRA (Biological) $321.62
- NUCALA (Biological) $300.43
- TEZSPIRE (Biological) $275.98
- Da Vinci Surgical System (Device) $264.27
- CHARTIS CATHETER (Device) $145.83
- TRELEGY ELLIPTA (Drug) $144.53
- GIAPREZA (Drug) $133.17
- YUPELRI (Drug) $126.44
- ZEPHYR DELIVERY CATHETER (Device) $121.11
- GLASSIA (Biological) $113.35
- TYVASO (Drug) $74.21
- Impella (Device) $60.05
- Prolastin-C Liquid (Biological) $57.80
- (8874) inCourage (Device) $52.69
- DUPIXENT (Biological) $51.47
- GORE ENFORM Preperitoneal Biomaterial (Device) $50.70
- TE7 MAX (Device) $44.81
- DIFICID (Drug) $40.86
- ELIQUIS (Drug) $36.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Hackensack
Dr. Emanuele Santomauro, Md, MD
Pulmonary Disease — Payments: $383,229
Pulmonary Disease $383,229
Dr. Nadeem Ali, M.d, M.D
Pulmonary Disease — Payments: $65,634
Pulmonary Disease $65,634
Dr. David Orr, Do, DO
Pulmonary Disease — Payments: $14,176
Pulmonary Disease $14,176
Dr. John Villa, Do, DO
Pulmonary Disease — Payments: $14,032
Pulmonary Disease $14,032
Dr. Keith Rose, M.d, M.D
Pulmonary Disease — Payments: $12,026
Pulmonary Disease $12,026
Dr. Sean Sadikot, M.d, M.D
Pulmonary Disease — Payments: $6,912
Pulmonary Disease $6,912